NEA Management Company’s Tempest Therapeutics TPST Stock Holding History

NEA Management Company’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,060	Closed	-$622K	–	59
2021 Q4	$622K	Hold	9,060	–	–	0.01%	57
2021 Q3	$1.7M	Hold	9,060	–	–	0.02%	59
2021 Q2	$1.32M	Hold	9,060	–	–	0.02%	60
2021 Q1	$2.12M	Hold	9,060	–	–	0.05%	55
2020 Q4	$3.78M	Hold	9,060	–	–	0.1%	54
2020 Q3	$2.88M	Hold	9,060	–	–	0.12%	47
2020 Q2	$3.11M	Hold	9,060	–	–	0.13%	42
2020 Q1	$9.33M	Hold	9,060	–	–	0.49%	31
2019 Q4	$11.9M	Hold	9,060	–	–	0.56%	28
2019 Q3	$12.6M	Hold	9,060	–	–	1.04%	22
2019 Q2	$20.4M	Hold	9,060	–	–	1.43%	19
2019 Q1	$26.5M	Hold	9,060	–	–	1.38%	20
2018 Q4	$14M	Buy	+9,060	New	+$18.6M	0.56%	27

Other funds holding TPST

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NEA Management Company's TPST Position: Q1 2022 in Review

NEA Management Company sold out of Tempest Therapeutics (TPST) in Q1 2022, closing a stake of 9,060 shares — an estimated $622K sold.

NEA Management Company first reported a position in TPST in Q4 2018 and held it in 13 quarters. The position peaked at $26.5M in Q1 2019. 15 funds tracked by Wall St. Rank hold TPST as of Q1 2022.

NEA Management Company reported no remaining Tempest Therapeutics position as of Q1 2022 after selling out during the quarter.
NEA Management Company sold 9,060 Tempest Therapeutics shares in Q1 2022, an estimated $622K.
NEA Management Company first reported a position in Tempest Therapeutics in Q4 2018 and held it in 13 quarters.
NEA Management Company's Tempest Therapeutics position peaked at $26.5M in Q1 2019.
15 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2022.

Based on NEA Management Company's 13F filing for Q1 2022, filed 16 May 2022.